ReviewFrontiers in oncology2022
Measurable residual disease in hairy cell leukemia: Technical considerations and clinical significance.
Tadeusz Robak et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it